Discover IceCure Breast Cryoablation at ECIO 2026: Join us at the European Conference on Interventional Oncology in Basel

IceCure Invitation to ECIO 2026 in Basel.

Join IceCure at the European Conference on Interventional Oncology (ECIO) in Basel, Switzerland from April 26 – 30. Discover how our liquid nitrogen-based ProSense™ Cryoablation system is giving clinicians new choices in interventional oncology at Booth #4. IceCure is proud to be a silver sponsor at ECIO 2026, one of the leading global meetings dedicated to minimally invasive image-guided cancer […]

Cryoablation Eases Pain for Terror Victim

Cryoablation, the process of destroying tissue with ultra-low freezing temperatures, is being used around the world to treat a growing number of clinical indications. In many cases, the driving force behind a novel use of cryoablation is driven not by researchers or physicians, but by the patients themselves. In this blog, we highlight the case […]

Cancer in Kidney Transplant Patients – Occurrence Frequency & Treatment Options 

Kidney disease, Chronic kidney disease ckd, Doctor with human model to study and treat in hospital.

Many kidney transplant patients are overcoming the immediate threat of kidney disease only to face the challenge of a cancer diagnosis. This has many implications but for those who face kidney cancer in their transplanted kidney, it’s essential to find a suitable treatment.  For a kidney recipient who has only one kidney, cryoablation offers a […]

Is cryo-immunology the next frontier for cryoablation? 

Cryoablation represents a frontier in minimally invasive cancer treatment, offering a novel approach to the destruction of both benign and malignant tumors. This procedure leverages extreme cold, applied directly to the tumor site, to induce cell death without the need for traditional surgical removal. The appeal of cryoablation lies in its simplicity and the reduced […]